Catalyst Wire Dossier Catalyst Wire Dossier

GLUCAGON

GLUCAGON · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

62 regulatory and trial events tracked for GLUCAGON, covering 2009-05-07 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes [NA]

See pricing